All News about Revance Therapeutics
NASDAQ:RVNC Shareholder Alert: Investigation over Potential Wrongdoing at Revance Therapeutics, Inc.
December 06, 2021
Via SBWire
Exposures
Product Safety
Via NewMediaWire
Topics
Lawsuit
Via NewMediaWire
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.